Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC268

Lanadelúmab

  • Status:
    Veitt
  • Application date:
    6.5.2019
  • Application published:
    15.5.2019
  • Grant published:
    15.9.2021
  • Max expiry date:
    25.11.2033
  • Medicine name:
    Takhzyro
  • Medicine for children:
    No

Timeline

Today
6.5.2019Application
15.5.2019Publication
15.9.2021Registration
25.11.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1340/001
  • Date:
    5.12.2018
  • Foreign authorization number:
    EU/1/18/1340
  • Date:
    22.11.2018

Owner

  • Name:
    Takeda Pharmaceutical Company Limited
  • Address:
    1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents